About 69% of respondents were not aware of the age at risk for the development of prostate cancer, 81.2% reported that they had no prior knowledge about PSA and DRE screening methods, 51.8% believed that prostate cancer could be treated, 35.9% did not know, while 12.2% said it could not be treated. This evidence concerns the gene KLK3 and prostate cancer.